Prof. Dr. Pablo Demelo-Rodríguez received his Doctor of Medicine degree from the Complutense University of Madrid (2019) on direct oral anticoagulants in venous thromboembolic disease. He then became a Specialist in Internal Medicine (Gregorio Marañón Hospital, 2010-2015). He received his Master's in Systemic Autoimmune Diseases from the University of Barcelona (2015), Master's in Lysosomal Diseases from the University of Alcalá de Henares (2017), and Master's in Anticoagulant Treatment from the Universidad Católica San Antonio de Murcia (2020). Since 2015, he has worked as an assistant in the Venous Thromboembolic Disease Unit of the Gregorio Marañón Hospital. As a researcher, he has participated in clinical trials of new oral anticoagulants. Since 2013, he has been an active member of RIETE and its working group. In the last year, he has focused his research activity on venous thromboembolic disease and COVID-19. As a teacher, he has been an Associate Professor of General Pathology at the Complutense University of Madrid since 2017. In addition, he has been an associate professor of the subjects General Pathology and Emergencies at the CEU San Pablo University since 2015. As a speaker, he has participated in related national and international conferences regarding thromboembolic diseases.
Hospital General Universitario Gregorio Marañón
Madrid, Spain